3/2/2011Case-control studies1 Study designs: Case-control studies Victor J. Schoenbach, PhD home page Department of Epidemiology Gillings School of Global.

Slides:



Advertisements
Similar presentations
Chapter 16 Inferential Statistics
Advertisements

Test for Dementia Following are four questions and a bonus question. In order for the test to be accurate, you have to answer each question instantly.
Data Analysis Basics for Analytic Epidemiology Session 3, Part 3.
Hypothesis Testing A hypothesis is a claim or statement about a property of a population (in our case, about the mean or a proportion of the population)
HUDM4122 Probability and Statistical Inference March 30, 2015.
1 Case-Control Study Design Two groups are selected, one of people with the disease (cases), and the other of people with the same general characteristics.
Measures of Disease Association Measuring occurrence of new outcome events can be an aim by itself, but usually we want to look at the relationship between.
Relative and Attributable Risks. Absolute Risk Involves people who contract disease due to an exposure Doesn’t consider those who are sick but haven’t.
Measure of disease frequency
Measures of association
1 The Basics of Regression Regression is a statistical technique that can ultimately be used for forecasting.
Let’s find out just how smart and clever you really are!
Need to know in order to do the normal dist problems How to calculate Z How to read a probability from the table, knowing Z **** how to convert table values.
Main Points to be Covered Cumulative incidence using life table method Difference between cumulative incidence based on proportion of persons at risk and.
HaDPop Measuring Disease and Exposure in Populations (MD) &
Inferential Statistics
Lecture 9: p-value functions and intro to Bayesian thinking Matthew Fox Advanced Epidemiology.
Incidence and Prevalence
Are exposures associated with disease?
Study Design and Analysis in Epidemiology: Where does modeling fit? Meaningful Modeling of Epidemiologic Data, 2010 AIMS, Muizenberg, South Africa Steve.
Cohort Study.
Hadpop Calculations. Odds ratio What study applicable? Q. It is suggested that obesity increases the chances on an individual becoming infected with erysipelas.
Multiple Choice Questions for discussion
EPI 811 – Work Group Exercise #2 Team Honey Badgers Alex Montoye Kellie Mayfield Michele Fritz Anton Frattaroli.
Confidence Intervals Nancy D. Barker, M.S.. Statistical Inference.
Ch 8 Estimating with Confidence. Today’s Objectives ✓ I can interpret a confidence level. ✓ I can interpret a confidence interval in context. ✓ I can.
Retrospective Cohort Study. Review- Retrospective Cohort Study Retrospective cohort study: Investigator has access to exposure data on a group of people.
QBM117 Business Statistics Estimating the population mean , when the population variance  2, is known.
Lecture 6 Objective 16. Describe the elements of design of observational studies: (current) cohort studies (longitudinal studies). Discuss the advantages.
 Is there a comparison? ◦ Are the groups really comparable?  Are the differences being reported real? ◦ Are they worth reporting? ◦ How much confidence.
Ch 8 Estimating with Confidence. Today’s Objectives ✓ I can interpret a confidence level. ✓ I can interpret a confidence interval in context. ✓ I can.
A Couple of Simple Tests Paul Morris CIS144 Week 7.
Psyc 235: Introduction to Statistics DON’T FORGET TO SIGN IN FOR CREDIT!
From Theory to Practice: Inference about a Population Mean, Two Sample T Tests, Inference about a Population Proportion Chapters etc.
Design and Analysis of Clinical Study 6. Case-control Study Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
A short introduction to epidemiology Chapter 2b: Conducting a case- control study Neil Pearce Centre for Public Health Research Massey University Wellington,
Approaches to the measurement of excess risk 1. Ratio of RISKS 2. Difference in RISKS: –(risk in Exposed)-(risk in Non-Exposed) Risk in Exposed Risk in.
Causation ? Tim Wiemken, PhD MPH CIC Assistant Professor Division of Infectious Diseases University of Louisville, Kentucky.
01/20151 EPI 5344: Survival Analysis in Epidemiology Epi Methods: why does ID involve person-time? March 10, 2015 Dr. N. Birkett, School of Epidemiology,
01/20141 EPI 5344: Survival Analysis in Epidemiology Epi Methods: why does ID involve person-time? March 13, 2014 Dr. N. Birkett, Department of Epidemiology.
Contingency tables Brian Healy, PhD. Types of analysis-independent samples OutcomeExplanatoryAnalysis ContinuousDichotomous t-test, Wilcoxon test ContinuousCategorical.
1 Psych 5500/6500 The t Test for a Single Group Mean (Part 1): Two-tail Tests & Confidence Intervals Fall, 2008.
Epidemiologic design from a sampling perspective Epidemiology II Lecture April 14, 2005 David Jacobs.
Measures of Association and Impact Michael O’Reilly, MD, MPH FETP Thailand Introductory Course.
Leicester Warwick Medical School Health and Disease in Populations Case-Control Studies Paul Burton.
Understanding Medical Articles and Reports Linda Vincent, MPH UCSF Breast SPORE Advocate September 24,
1 EPI 5240: Introduction to Epidemiology Measures used to compare groups October 5, 2009 Dr. N. Birkett, Department of Epidemiology & Community Medicine,
6.1 Inference for a Single Proportion  Statistical confidence  Confidence intervals  How confidence intervals behave.
Introduction to Inference: Confidence Intervals and Hypothesis Testing Presentation 4 First Part.
BC Jung A Brief Introduction to Epidemiology - XIII (Critiquing the Research: Statistical Considerations) Betty C. Jung, RN, MPH, CHES.
Organization of statistical research. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and.
Test for early dementia Monroe Instructions Answer quickly. Do not discuss answers.
BIOSTATISTICS Lecture 2. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and creating methods.
A short introduction to epidemiology Chapter 2: Incidence studies Neil Pearce Centre for Public Health Research Massey University Wellington, New Zealand.
A short introduction to epidemiology Chapter 6: Precision Neil Pearce Centre for Public Health Research Massey University Wellington, New Zealand.
Statistics 19 Confidence Intervals for Proportions.
2 3 انواع مطالعات توصيفي (Descriptive) تحليلي (Analytic) مداخله اي (Interventional) مشاهده اي ( Observational ) كارآزمايي باليني كارآزمايي اجتماعي كارآزمايي.
Measures of Association (2) Attributable Risks and fractions October Epidemiology 511 W. A. Kukull.
Relative and Attributable Risks
EPID 503 – Class 12 Cohort Study Design.
Sample size calculation
Epidemiologic Measures of Association
Random error, Confidence intervals and P-values
Lecture 1: Fundamentals of epidemiologic study design and analysis
Intro to Statistical Inference
Test-taking Strategies That Work!
Interpreting Basic Statistics
Measures of Disease Occurrence
Module appendix - Attributable risk
A TEST of THINKING OUTSIDE the BOX
Presentation transcript:

3/2/2011Case-control studies1 Study designs: Case-control studies Victor J. Schoenbach, PhD home page Department of Epidemiology Gillings School of Global Public Health University of North Carolina at Chapel Hill Principles of Epidemiology for Public Health (EPID600)

10/7/2008Case-control studies2 From my uncle Are you the weakest link? Below are four (4) questions. You have to answer them instantly. You can't take your time, answer all of them immediately. OK? Let's find out just how clever you really are. Ready?

10/7/2008Case-control studies3 Question 1 You are participating in a race. You overtake the second person. Question: What position are you in?

10/7/2008Case-control studies4 Question 1 – answer If you answer that you are first, then you are absolutely wrong! Answer: If you overtake the second person and you take his place, you are second!

10/7/2008Case-control studies5 On to question 2 Try not to screw up on the next question. To answer the second question, don't take as much time as you took for the first question.

10/7/2008Case-control studies6 Question 2 Question: If you overtake the last person, then you are …?

10/7/2008Case-control studies7 Question 2 – answer Answer: If you answered that you are second to last, then you are wrong again. Tell me, how can you overtake the LAST person?! …? You're not very good at this are you?

10/7/2008Case-control studies8 On to question 3 The third question is very tricky math! Note: This must be done in your head only. Do NOT use paper and pencil or a calculator. Try it.

10/7/2008Case-control studies9 Question 3 – what is the total? Take 1000 and add 40 to it. Now add another Now add 30. Add another Now add 20. Now add another Now add 10.

10/7/2008Case-control studies10 Question 3 – answer Did you get 5,000? The correct answer is actually 4,100. Don't believe it? Check with your calculator!

10/7/2008Case-control studies11 On to question 4 Today is definitely not your day. Maybe you will get the last question right?

10/7/2008Case-control studies12 Question 4 Mary's father has five daughters: 1. Nana, 2. Nene, 3. Nini, 4. Nono. Question: What is the name of the fifth daughter?

10/7/2008Case-control studies13 Question 4 – answer Answer: Nunu? NO! Of course not. Her name is Mary. Read again. (“Mary's father has five daughters.…”) You ARE the WEAKEST LINK!!!!!! Good- bye!!! (With Love, Your Uncle)

10/7/2008Case-control studies14 Plan for this lecture Confidence intervals and significance tests (read only) Incidence density and cumulative incidence (brief) Attributable risk (brief) Theoretical overview of case-control studies as a complement to the traditional perspective

10/7/2008Case-control studies15 Confidence intervals & significance tests Everything you’ve been told so far about confidence intervals and statistical significance is probably misleading, including this statement. I am not licensed to teach statistics, so what I say on this topic mustn’t leave this room!

10/7/2008Case-control studies16 Confidence intervals “a plausible range of values for the unknown population parameter” Michael Oakes, Statistical inference, p.52 Exact interpretation is problematic We are more confident that a 95% interval covers the parameter than a 90% interval, but the 95% interval is wider (provides a less precise estimate)

10/7/2008Case-control studies17 Significance tests “It might be argued that the significance test, if properly understood, does no harm. This is, perhaps, fair comment, but anyone who appreciates the force of the case presented in this chapter will realize that equally, it does very little good.” Michael Oakes, Statistical inference, p.72

10/7/2008Case-control studies18 Incidence rate and incidence proportion [incidence density and cumulative incidence]

10/7/2008Case-control studies19 IR (ID) and IP in a closed cohort } CI } 1 – CI T0T0 T1T1

10/7/2008Case-control studies20 Attributable risk

10/7/2008Case-control studies21 Attributable risk Assume that we know a causal factor for a disease. Conceptually, the “attributable risk” for that factor is: 1. difference in risk or incidence between exposed and unexposed people or 2. difference in risk or incidence between total population and unexposed people

10/7/2008Case-control studies22 Attributable risk Attributable risk can be presented as: 1. an “absolute” number, e.g., “80,000, or 20 per 100 cases/year of stroke are attributable to smoking” 2. a “relative” number, e.g., “20% of stroke cases are attributable to smoking”. (analogy: a wage increase in a part-time job: $ increase, % increase in wage, % increase in income)

10/7/2008Case-control studies23 For relative measures, think of % of cases People Incidence rate or proportions

10/7/2008Case-control studies24 For relative measures, think of % of cases Substitute population Caseload

10/7/2008Case-control studies25 For relative measures, think of % of cases Caseload

10/7/2008Case-control studies26 Case-control studies

10/8/2001Case-control studies27 Case-control studies Traditional view: compare - people who get the disease - people who do not get the disease “Controls” a misnomer, derived from faulty analogy to controls in experiment Modern conceptualization: controls are a “window” into the “study base”

10/7/2008Case-control studies28 Case-control studies

10/7/2008Case-control studies29 Population at risk (N=200)        

10/7/2008Case-control studies30         O Week 1 O

10/7/2008Case-control studies31         O Week 2 O O O O

10/7/2008Case-control studies32         O O O Week 3 O O O O

10/7/2008Case-control studies33 Incidence rate (“incidence density”) Number of new cases IR = ––––––––––––––––––– Population time

6/23/2002Case-control studies34 Incidence rate (“incidence density”) Number of new cases 7 IR = ––––––––––––––––––– = –––––– Population time ?

6/23/2002Case-control studies35 Incidence rate (“incidence density”) Population time at risk: 200 people for 3 weeks = 600 person-wks But 2 people became cases in 1st week 3 people became cases in 2nd week 2 people became cases in 3rd week Only 193 people at risk for 3 weeks

6/23/2002Case-control studies36 Incidence rate (“incidence density”) Assume that: 2 people who became cases in 1st week were at risk for 0.5 weeks each = 0.5 = people who became cases in 2nd week were at risk for 1.5 weeks each = 1.5 = people who became cases in 3rd week were at risk for 2.5 weeks each = 2.5 = 5.0

6/23/2002Case-control studies37 Incidence rate (“incidence density”) Total population-time = Cases occuring during week 1: 1.0 p-w Cases occuring during week 2: 4.5 p-w Cases occuring during week 3: 5.0 p-w Non-cases: 193 x 3 = p-w p-w

6/23/2002Case-control studies38 Incidence rate (“incidence density”) 7 IR = –––––– = cases / person-wk average over 3 weeks Number of new cases IR = ––––––––––––––––––– Population time

3/2/2011Case-control studies39 Incidence proportion (“cumulative incidence”) Number of new cases CI = ––––––––––––––––––– Population at risk

10/7/2008Case-control studies40 Incidence proportion (“cumulative incidence”) 7 3-week CI = –––– = Number of new cases CI = ––––––––––––––––––– Population at risk

10/7/2008Case-control studies41 Can estimate incidence in people who are “exposed”    O Week 1

10/7/2008Case-control studies42 Can estimate incidence in people who are “exposed”    O Week 2 O O

10/7/2008Case-control studies43 Can estimate incidence in people who are “exposed”    O Week 3 O O O

10/7/2008Case-control studies44 Can estimate incidence in people who are “unexposed”      O Week 1

10/7/2008Case-control studies45 Can estimate incidence in people who are “unexposed”      O Week 2 O

10/7/2008Case-control studies46 Can estimate incidence in people who are “unexposed”      O Week 3 O O

10/7/2008Case-control studies47 Entire population, week 1    O      O

10/7/2008Case-control studies48 Entire population, week 2         O O O O O

10/7/2008Case-control studies49 Entire population, week 3         O O O O O O O

10/7/2008Case-control studies50 Incidence rate (“incidence density”) Number of new cases IR = ––––––––––––––––––– Population time

10/7/2008Case-control studies51 Incidence rate in exposed during three weeks 4 4 IR = –––––––––––––– = –––– = / wk Number of new cases IR = ––––––––––––––––––– Population time

10/7/2008Case-control studies52 Incidence rate in unexposed during three weeks 3 3 IR = –––––––––––––––––– = ––––– = / wk Number of new cases IR = ––––––––––––––––––– Population time

10/7/2008Case-control studies53 Compare incidence rates in exposed and unexposed

10/7/2008Case-control studies54 Difference between incidence rates in exposed and unexposed Incidence rate difference (IRD, IDD) = (0.018 – 0.008) / wk = / week How to interpret?

10/7/2008Case-control studies55 Difference in incidence rates Incidence rate difference (IRD) = (0.018 – 0.008) / wk = / week “The rate in the exposed was / week greater than the rate in the unexposed.”

10/7/2008Case-control studies56 Relative difference in incidence rates in exposed and unexposed Relative incidence rate difference – = –––––––––––– = 2.25 – 1 = How to interpret?

10/7/2008Case-control studies57 Relative difference in incidence rates Relative incidence rate difference – = –––––––––––– = 2.25 – 1 = “The rate in the exposed was 125% greater than the rate in the unexposed.”

10/7/2008Case-control studies58 Ratio of incidence rates in exposed and unexposed Incidence rate ratio = –––––– = 2.25 (IRR, IDR) How to interpret?

10/7/2008Case-control studies59 Ratio of incidence rates Incidence rate ratio = –––––– = 2.25 (IRR, IDR) “The rate in the exposed was 2.25 times the rate in the unexposed.” [not “times greater”]

6/23/2002Case-control studies60 Estimating IRR and CIR with the Odds Ratio

2/28/2006Case-control studies61 Odds odds = probability / (1 – probability) odds = risk / (1 – risk) (most commonly)

1/29/2007Case-control studies62 For small probability, odds ≈ probability Odds Small p

1/29/2007Case-control studies63 Odds = probability / (1 – probability) Odds

1/29/2007Case-control studies64 Odds Any ratio of two natural numbers can be regarded as an odds: Exposed: 20 Unexposed: 30 Total: 50 Odds of exposure: 20/50 divided by 30/50

1/29/2007Case-control studies65 Incidence rate ratio (a.k.a. “incidence density ratio”) can be expressed as a ratio of odds

10/7/2008Case-control studies66 Incidence rate ratio IR in exposed IR 1 IRR = ––––––––––––––– = –––– IR in unexposed IR 0

1/29/2007Case-control studies67 Incidence rate ratio IR 1 Exposed cases / Exp PT IRR = –––– = ––––––––––––––––––––––––– IR 0 Unexposed cases / Unexp PT (PT = “population time”)

10/7/2008Case-control studies68 Incidence density ratio is a ratio of exposed to unexposed cases... IR 1 Exposed cases / Exp PT IRR = –––– = –––––––––––––––––––––––– IR 0 Unexposed cases / Unexp PT Exposed cases / Unexposed cases = ––––––––––––––––––––––––––––– Exposed PT / Unexposed PT

10/7/2008Case-control studies69... divided by a ratio of exposed to unexposed population-time IR 1 Exposed cases / Exp PT IRR = –––– = –––––––––––––––––––––––– IR 0 Unexposed cases / Unexp PT Exposed cases / Unexposed cases = –––––––––––––––––––––––––––– Exposed PT / Unexposed PT

10/7/2008Case-control studies70 Ratio of exposed to unexposed cases = “exposure odds” in cases Exposed cases / Unexposed cases IRR = ––––––––––––––––––––––––––––––– Exp Person-time / Unexp Person-time “Exposure odds” in cases = –––––––––––––––––––––––––– “Exposure odds” in population

10/7/2008Case-control studies71 Ratio of exposed to unexposed population-time = “exposure odds” Exposed cases / Unexposed cases IRR = –––––––––––––––––––––––––––––––– Exp Person-time / Unexp Person-time “Exposure odds” in cases = ––––––––––––––––––––––––––– “Exposure odds” in population

10/7/2008Case-control studies72 Count exposed and unexposed cases         O O O O O O O

10/7/2008Case-control studies73 From before: Exposed: 4 4 IR = –––––––––––––– = –––– = / wk Unexposed: 3 3 IR = –––––––––––––––––– = ––––– = / wk

2/28/2006Case-control studies74 Exposure odds in cases = Exposed cases / Unexposed cases = (4/7) / (3/7) = 4 / 3 = 1.33 The exposure odds in cases are 1.33

10/7/2008Case-control studies75 From before: Exposed: 4 4 ID = –––––––––––––– = –––– = / wk Unexposed: 3 3 ID = –––––––––––––––––– = ––––– = / wk

10/7/2008Case-control studies76 Exposure odds in population-time = Exp. person-time / Unexp. person-time = ( ) / ( ) = 219 / = 0.59 The exposure odds in population-time are 0.59

10/7/2008Case-control studies77 So incidence rate ratio can be expressed as a ratio of odds “Exposure odds” in cases IRR = ––––––––––––––––––––––––– “Exposure odds” in population 1.33 = –––––– = 2.25 (same as earlier) 0.59

1/29/2007Case-control studies78         O O O O O O O Can we estimate exposure odds in the population by taking a sample?

1/29/2007Case-control studies79 Take sample of “risk set” – “density controls” – week 1    O      O

10/7/2008Case-control studies80 Take sample of “risk set” – “density controls” – week 2         O O O O O

2/28/2006Case-control studies81 Take sample of “risk set” – “density controls” – week 3         O O O O O O O

10/7/2008Case-control studies82 Now estimate incidence rate ratio using the “density controls” IR 1 Exposed cases / Unexposed cases IRR = –––– = ––––––––––––––––––––––––––– IR 0 Exposed PT / Unexposed PT

10/7/2008Case-control studies83 Estimating the population odds with the odds in the control group Exposed cases / Unexposed cases IDR = ––––––––––––––––––––––––––––––– Exposed controls / Unexposed controls We call this the “exposure odds ratio” (OR).

3/4/2002Case-control studies84 Exposure odds ratio = estimates incidence rate ratio (a.k.a. IDR) OR = ––––– = ––––– = /

1/29/2007Case-control studies85 Odds ratio from a 2 x 2 table

3/4/2002Case-control studies86 Odds ratio from a 2 x 2 table

10/7/2008Case-control studies87 What about incidence proportion in a cohort? (“cumulative incidence”) Number of new cases 3-week CI = ––––––––––––––––––– Population at risk

10/7/2008Case-control studies88 Population at risk – baseline        

10/7/2008Case-control studies89 Entire population, week 3         O O O O O O O

10/7/2008Case-control studies90 Cumulative incidence in exposed Number of new exposed cases 3-week CI = ––––––––––––––––––––––––––– Exposed population at risk 4 3-week CI = –––– =

10/7/2008Case-control studies91 Cumulative incidence in unexposed Number of new unexposed cases 3-week CI = –––––––––––––––––––––––––––– Unexposed population at risk 3 3-week CI = –––– =

10/7/2008Case-control studies92 Compare incidence proportions in exposed and unexposed

10/7/2008Case-control studies93 Difference in incidence proportions between exposed and unexposed 3-wk cumulative incidence difference (CID) = (0.053 – 0.024) = How to interpret?

10/7/2008Case-control studies94 Difference in incidence proportions 3-wk cumulative incidence difference (CID) = (0.053 – 0.024) = “The 3-week cumulative incidence in the exposed was greater than in the unexposed.”

10/7/2008Case-control studies95 Relative difference in incidence proportions for exposed and unexposed 3-wk cumulative incidence relative difference (0.053 – 0.024) = –––––––––––––– = –––––– = How to interpret?

10/7/2008Case-control studies96 Relative difference in incidence proportions 3-wk cumulative incidence relative difference (0.053 – 0.024) = –––––––––––––– = –––––– = “The 3-week CI in the exposed was 122% greater than in the unexposed.”

1/29/2007Case-control studies97 Ratio of incidence proportions for exposed and unexposed 3-week cumulative incidence ratio (CIR) = (0.053 / 0.024) = 2.22 How to interpret?

10/7/2008Case-control studies98 Ratio of incidence proportions (“relative risk”, “risk ratio”) 3-week cumulative incidence ratio (CIR) = (0.053 / 0.024) = 2.22 “The 3-week CI in the exposed was 2.2 times that in the unexposed.” [not “times greater than”]

10/7/2008Case-control studies99 Ratio of incidence proportions, a.k.a. cumulative incidence ratio CI 1 Exposed cases / Exp PAR CIR = –––– = –––––––––––––––––––––––––– CI 0 Unexposed cases / Unexp PAR

10/7/2008Case-control studies100 Cumulative incidence ratio can also be expressed as a ratio of odds of exposure in cases divided by... CI 1 Exposed cases / Exp PAR CIR = –––– = –––––––––––––––––––––––––– CI 0 Unexposed cases / Unexp PAR Exposed cases / Unexposed cases = ––––––––––––––––––––––––––––– Exp PAR / Unexp PAR

10/7/2008Case-control studies an odds of exposure in the population at risk (PAR) CI 1 Exposed cases / Exp PAR CIR = –––– = –––––––––––––––––––––––––– CI 0 Unexposed cases / Unexp PAR Exposed cases / Unexposed cases = ––––––––––––––––––––––––––––– Exp PAR / Unexp PAR

10/7/2008Case-control studies102 So cumulative incidence ratio is also an odds ratio CI 1 Exposed cases / Unexposed cases CIR = ––– = ––––––––––––––––––––––––––– CI 0 Exp PAR / Unexp PAR Exposure odds in cases = ––––––––––––––––––––––––––––––– Exposure odds in population at risk

10/7/2008Case-control studies103 Exposure odds in cases = Exposed cases / Unexposed cases = 4 / 3 = 1.33 (same as for incidence density ratio)

10/7/2008Case-control studies104 Population at risk (before cases occur)        

1/29/2007Case-control studies105 Exposure odds in population at risk (before cases occur) = Exposed PAR / Unexposed PAR = 75 / 125 = 0.60 (slightly different from odds of exposure for person-time)

10/7/2008Case-control studies106 So cumulative incidence ratio is also an odds ratio CI 1 Exposure odds in cases CIR = –––– = –––––––––––––––––––––––– CI 0 Exposure odds in pop. at risk week CIR = ––––– =

10/7/2008Case-control studies107 So if can estimate exposure odds in PAR, may not need to analyze entire cohort “Case-cohort” or “case-base” design Can be very advantageous if, for example, one wants to analyze specimens stored at baseline.

10/7/2008Case-control studies108 Sample from population at risk (before cases occur)        

10/7/2008Case-control studies109 Exposure odds in controls = Exp. controls / Unexp. controls = 6 / 10 = 0.60 (expected value for the estimated odds)

10/7/2008Case-control studies110 Cumulative incidence ratio CI 1 Exposed odds in cases CIR = ––– = ––––––––––––––––––––––– CI 0 Exposure odds in population wk CIR = exposure OR = ––––– =

10/7/2008Case-control studies111 What if cannot sample population at risk? Draw controls from noncases at end of follow-up period

10/7/2008Case-control studies112 Non-cases at end of follow-up         O O O O O O O

10/7/2008Case-control studies113 Exposure odds in population at risk (after cases occur) = Exposed noncases / Unexp. noncases = 71 / 122 = 0.58 (slightly different from ratio of person-time and ratio of population at risk)

10/7/2008Case-control studies114 Odds ratio Exposed odds in cases OR = –––––––––––––––––––––––– Exposure odds in population 1.33 = ––––– = (slightly larger than CIR)

1/29/2007Case-control studies115 Draw controls from noncases         O O O O O O O 5 9

10/7/2008Case-control studies116 Exposure odds in “cumulative” controls = Exposed noncases / Unexp. noncases = 5 / 9 (about) = 0.58 (Note: 5/9=0.555, but a larger “sample” would produce 0.58)

10/7/2008Case-control studies117 Odds ratio Exposed odds in cases OR = –––––––––––––––––––––––– Exposure odds in population 1.33 = ––––– = (slightly larger than CIR)

1/29/2007Case-control studies118 Case-control design is an efficient sampling technique Much more efficient, especially for rare outcomes Validity depends upon whether controls provide a clear view of population from which cases arise Susceptible to various sources of bias

10/7/2008Case-control studies119 New Software for Psychics “Notice to user: By breaking the seal of this envelope, you accept the terms of the enclosed license agreement.” – Adobe Font Pack for Windows Source: Willmott, Don, Abort, Retry, Fail? PC Magazine, June 14, 1994, 482.